 field trial oral cholera vaccin bangladesh serum vibriocid antitox antibodi marker risk cholera relationship serum vibriocid VC igg anti-cholera toxin CT risk cholera first year follow-up recipi oral dose subunit BS -whole-cel vaccin whole-cel vaccin escherichia strain placebo bangladesh acut sera cholera patient sera contemporan commun control VC titer averag reduct cholera risk group contrast group BS anti-ct titer cholera marker cholera risk vaccin protect efficaci cholera antibodi titer vaccin efficaci serum VC anti-ct antibodi poor marker longitudin pattern vaccin efficaci